 |
 |
I know, I know that I've been groaning about this for a while now. But what could there possibly be in the literature about pramipexole that the FDA could be looking over so carefully? Maybe they don't want to release an agonist with so few side effects. Just a little conspiracy theory from a paranoid brain. Jacob